These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10588994)
1. Montelukast, a leukotriene receptor antagonist, inhibits the late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats. Ihaku D; Cameron L; Suzuki M; Molet S; Martin J; Hamid Q J Allergy Clin Immunol; 1999 Dec; 104(6):1147-54. PubMed ID: 10588994 [TBL] [Abstract][Full Text] [Related]
2. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone. Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma. Wu AY; Chik SC; Chan AW; Li Z; Tsang KW; Li W Clin Exp Allergy; 2003 Mar; 33(3):359-66. PubMed ID: 12614451 [TBL] [Abstract][Full Text] [Related]
4. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739 [TBL] [Abstract][Full Text] [Related]
6. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model. Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427 [TBL] [Abstract][Full Text] [Related]
7. [The effect of montelukast on airway remodeling and the expression of interleukins and transforming growth factor-beta2 mRNA]. Bai JW; Deng WW; Wu HC Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):524-8. PubMed ID: 15388000 [TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma increases IL-12 mRNA expression and attentuates allergic late-onset airway responses in the Brown Norway rat. Isogai S; Hamid Q; Minshall E; Miyake S; Yoshizawa Y; Taha R; Toda M; Martin JG; Watanabe A Eur Respir J; 2000 Jul; 16(1):22-9. PubMed ID: 10933080 [TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice. Lee KS; Kim SR; Park HS; Park SJ; Min KH; Lee KY; Jin SM; Lee YC J Allergy Clin Immunol; 2007 Jan; 119(1):141-9. PubMed ID: 17208595 [TBL] [Abstract][Full Text] [Related]
10. Role of cysteinyl leukotrienes in CD4(+) T cell-driven late allergic airway responses. Hojo M; Suzuki M; Maghni K; Hamid Q; Powell WS; Martin JG J Pharmacol Exp Ther; 2000 May; 293(2):410-6. PubMed ID: 10773010 [TBL] [Abstract][Full Text] [Related]
11. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Wong WS; Zhu H; Liao W Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528 [TBL] [Abstract][Full Text] [Related]
12. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma. Frieri M; Therattil J; Wang SF; Huang CY; Wang YC Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337 [TBL] [Abstract][Full Text] [Related]
13. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Shimbori C; Shiota N; Okunishi H Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736 [TBL] [Abstract][Full Text] [Related]
14. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model. Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381 [TBL] [Abstract][Full Text] [Related]
15. Evidence for major basic protein immunoreactivity and interleukin 5 gene activation during the late phase response in explanted airways. Eidelman DH; Minshall E; Dandurand RJ; Schotman E; Song YL; Yasruel Z; Moqbel R; Hamid Q Am J Respir Cell Mol Biol; 1996 Nov; 15(5):582-9. PubMed ID: 8918365 [TBL] [Abstract][Full Text] [Related]
16. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802 [TBL] [Abstract][Full Text] [Related]
17. Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice. Mao H; Yin KS; Wang ZL; Li FY; Zhang XL; Liu CT; Lei S Chin Med J (Engl); 2004 Apr; 117(4):592-7. PubMed ID: 15109455 [TBL] [Abstract][Full Text] [Related]
18. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764 [TBL] [Abstract][Full Text] [Related]
19. A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat. Huang TJ; Adcock IM; Chung KF Br J Pharmacol; 2001 Nov; 134(5):1029-36. PubMed ID: 11682451 [TBL] [Abstract][Full Text] [Related]
20. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571. Blain JF; Sirois P Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]